boostagen Description

Boostagen is a sterile, whitish, cloudy and uniform suspension.
Each single dose (0.5 mL) contains: Tetanus Toxoid 7.5 Lf, Diphtheria Toxoid 2.0 Lf, Purified Bordetella pertusis antigens: Recombinant Pertussis Toxin (PT_gen) 5 µg, Filamentous Haemagglutinin (FHA) 5 µg.
Boostagen is a combined tetanus toxoid, reduced diphtheria toxoid and recombinant acellular pertussis vaccine (TdaP or TdaP_gen). This vaccine contains purified tetanus toxoid, diphtheria toxoid and purified Bordetella pertussis antigens (recombinant Pertussis Toxin and FHA). The recombinant Pertussis Toxin (rPT) is a genetically-detoxified PT (PT_gen) obtained by recombinant DNA technology. Boostagen meets the World Health Organisation (WHO) requirements for the manufacture of diphtheria, tetanus, and acellular pertussis combined vaccines.
Excipients/Inactive Ingredients: Excipients: aluminum hydroxide, sodium chloride, water for injection.
Other excipients in negligible amounts: hydrochloric acid and/or sodium hydroxide for pH adjustment; formaldehyde and thiomersal (an organomercuric compound) as manufacturing process residuals.